Bio-Path (NASDAQ:BPTH) Receives New Coverage from Analysts at StockNews.com
StockNews.com began coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a report issued on Monday morning. The firm issued a sell rating on the stock. Bio-Path Stock Performance Shares of NASDAQ:BPTH opened at $0.63 on Monday. The business’s 50 day simple moving average is $0.43 and its two-hundred day simple moving average is […]
More Stories
Iran Hasn’t Exported Crude Oil in 28 Days Amid US Blockade: Maritime Intelligence Company
By Victoria Friedman The Iranian regime has not been able to export any crude oil for nearly a month amid...
CIA Analysts Believed COVID-19 Came From Lab, Leaders Buried Assessments: Whistleblower
By Zachary Stieber CIA experts believed COVID-19 likely came from a laboratory in China, but leaders in the agency changed...
EBay Turns Down GameStop’s $55.5 Billion Takeover Proposal
By Andrew Moran EBay has turned down videogame retailer GameStop’s $55.5 billion takeover proposal. The online marketplace, in a May...
Trump Nominates Lake, Mastriano to Diplomatic Posts
By Kimberly Hayek President Donald Trump on Monday announced a slew of nominations sent to the U.S. Senate, including two...
Treasury Department Alerts US Banks to Suspected Iranian Money Laundering Efforts
By Victoria Friedman The U.S. Treasury Department’s Financial Crimes Enforcement Network (FinCEN) on May 11 issued an alert to financial...
Gas Prices Lift US Annual Inflation Rate to 3.8 Percent Highest Since May 2023
By Andrew Moran Consumer prices accelerated for the second straight month in April as the war in Iran added to...